Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century.
作者信息
Glynn Simone A, Busch Michael P, Dodd Roger Y, Katz Louis M, Stramer Susan L, Klein Harvey G, Simmons Graham, Kleinman Steven H, Shurin Susan B
机构信息
Transfusion Medicine and Cellular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
出版信息
Transfusion. 2013 Feb;53(2):438-54. doi: 10.1111/j.1537-2995.2012.03742.x. Epub 2012 Jun 13.
Abstract
摘要
相似文献
1
Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century.新兴传染病原体与国家血液供应：应对21世纪的潜在威胁
Transfusion. 2013 Feb;53(2):438-54. doi: 10.1111/j.1537-2995.2012.03742.x. Epub 2012 Jun 13.
2
Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.推进血液及血液制品新兴传染病风险评估：一次公开研讨会会议记录
Transfusion. 2013 Feb;53(2):455-63. doi: 10.1111/j.1537-2995.2012.03808.x. Epub 2012 Jul 31.
3
FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.美国食品药品监督管理局新兴传染病研讨会：评估新兴传染病对输血安全的影响
Transfusion. 2011 Aug;51(8):1855-71. doi: 10.1111/j.1537-2995.2011.03084.x. Epub 2011 Mar 10.
4
Reflections on the emergence of chikungunya virus in the United States: time to revisit a successful paradigm for the safety of blood-derived therapies.关于基孔肯雅病毒在美国出现的思考：是时候重新审视血液制品疗法安全性的成功范例了。
Transfusion. 2015 Jan;55(1):224-6. doi: 10.1111/trf.12933.
5
First "themed issue" of Transfusion on thirty years of progress in blood safety since recognition of transfusion-associated AIDS.《输血》关于自认识到输血相关艾滋病以来血液安全三十年进展的首个“主题专刊”。
Transfusion. 2013 Oct;53(10 Pt 2):2357-8. doi: 10.1111/trf.12376.
6
Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026).美国食品药品监督管理局2018年血液安全病原体减少技术公开研讨会会议记录（评论，第3026页）
Transfusion. 2019 Sep;59(9):3002-3025. doi: 10.1111/trf.15344. Epub 2019 May 29.
7
Babesia: an emerging infectious threat in transfusion medicine.巴贝斯虫：输血医学中一种新出现的感染威胁。
PLoS Pathog. 2013;9(7):e1003387. doi: 10.1371/journal.ppat.1003387. Epub 2013 Jul 11.
8
Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers.使用快速电子调查方法学估算献血者潜在暴露于新发传染病的风险：统计代表性抽样方法学在评估美国采供血机构风险中的应用。
Transfusion. 2020 Sep;60(9):1987-1997. doi: 10.1111/trf.15941. Epub 2020 Aug 3.
9
Researchers scan horizon for emerging infectious disease threats.研究人员扫视地平线，寻找新出现的传染病威胁。
Am J Health Syst Pharm. 2008 Dec 1;65(23):2190, 2192. doi: 10.2146/news080094.
10
Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk.新发传染病与血液安全：输血传播风险建模
Transfus Med Rev. 2017 Jul;31(3):154-164. doi: 10.1016/j.tmrv.2017.05.002. Epub 2017 May 15.
引用本文的文献
1
Trends of coinfections among healthy blood donors: COVID-19 pandemic repercussion.健康献血者中合并感染的趋势：COVID-19大流行的影响。
J Family Med Prim Care. 2024 Oct;13(10):4394-4398. doi: 10.4103/jfmpc.jfmpc_120_24. Epub 2024 Oct 18.
2
Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases.利用供体人群研究输血传播和新发传染病的流行病学和发病机制。
Transfus Med Rev. 2023 Oct;37(4):150769. doi: 10.1016/j.tmrv.2023.150769. Epub 2023 Oct 4.
3
Association of ABO and RhD blood groups with the risk of HIV infection.ABO 和 RhD 血型与 HIV 感染风险的关联。
PLoS One. 2023 Apr 26;18(4):e0284975. doi: 10.1371/journal.pone.0284975. eCollection 2023.
4
A systematic review, umbrella review, and quality assessment on clinical translation of stem cell therapy for knee osteoarthritis: Are we there yet?系统评价、伞式评价和对干细胞治疗膝骨关节炎的临床转化的质量评估：我们做到了吗？
Stem Cell Res Ther. 2023 Apr 15;14(1):91. doi: 10.1186/s13287-023-03332-5.
5
How do we…form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?我们如何……在采供血行业内组建并协调全国性的 SARS-CoV-2 血清学调查？
Transfusion. 2022 Jul;62(7):1321-1333. doi: 10.1111/trf.16943. Epub 2022 Jun 15.
6
Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma.氨甲蝶呤和长波紫外线 A 光疗能有效使人类血浆中的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）失活。
Vox Sang. 2021 Jul;116(6):673-681. doi: 10.1111/vox.13043. Epub 2020 Dec 5.
7
An analysis on HBsAg, Anti-HCV, Anti-HIV½ and VDRL test results in blood donors according to gender, age range and years.对不同性别、年龄范围和献血年份的献血者的 HBsAg、抗-HCV、抗-HIV1/2 和 VDRL 检测结果进行分析。
PLoS One. 2019 Sep 19;14(9):e0219709. doi: 10.1371/journal.pone.0219709. eCollection 2019.
8
Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026).美国食品药品监督管理局2018年血液安全病原体减少技术公开研讨会会议记录（评论，第3026页）
Transfusion. 2019 Sep;59(9):3002-3025. doi: 10.1111/trf.15344. Epub 2019 May 29.
9
A microarray-based pathogen chip for simultaneous molecular detection of transfusion-transmitted infectious agents.基于微阵列的病原体芯片，用于同时分子检测输血传播的传染性病原体。
J Transl Med. 2019 May 14;17(1):156. doi: 10.1186/s12967-019-1905-4.
10
Expression, Purification, and Characterization of Recombinant Human α-Antitrypsin Produced Using Silkworm-Baculovirus Expression System.利用家蚕杆状病毒表达系统表达、纯化和鉴定重组人α-抗胰蛋白酶。
Mol Biotechnol. 2018 Dec;60(12):924-934. doi: 10.1007/s12033-018-0127-y.
本文引用的文献
1
The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors.美国克氏锥虫感染研究：在美国献血者中，导致查加斯病的寄生虫经媒介传播的证据。
Transfusion. 2012 Sep;52(9):1922-30. doi: 10.1111/j.1537-2995.2012.03581.x. Epub 2012 Mar 8.
2
Multiple sources of contamination in samples from patients reported to have XMRV infection.从报告有 XMRV 感染的患者样本中发现了多种污染源。
PLoS One. 2012;7(2):e30889. doi: 10.1371/journal.pone.0030889. Epub 2012 Feb 20.
3
Absence of XMRV in peripheral blood mononuclear cells of ARV-treatment naïve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors.未在未经抗逆转录病毒治疗的 HIV-1 感染者和 HIV-1/HCV 合并感染者以及献血者的外周血单个核细胞中检测到 XMRV。
PLoS One. 2012;7(2):e31398. doi: 10.1371/journal.pone.0031398. Epub 2012 Feb 13.
4
Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico.在 2007 年波多黎各登革热疫情期间，通过 RNA 鉴定献血者中的登革热病毒血症，并检测到登革热输血传播。
Transfusion. 2012 Aug;52(8):1657-66. doi: 10.1111/j.1537-2995.2012.03566.x. Epub 2012 Feb 17.
5
Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission.在北美洲和西班牙的克氏锥虫感染：支持输血传播的证据。
Transfusion. 2012 Sep;52(9):1913-21; quiz 1912. doi: 10.1111/j.1537-2995.2011.03554.x. Epub 2012 Feb 10.
6
Failure to Detect XMRV-Specific Antibodies in the Plasma of CFS Patients Using Highly Sensitive Chemiluminescence Immunoassays.使用高灵敏度化学发光免疫分析法未能在慢性疲劳综合征患者血浆中检测到XMRV特异性抗体。
Adv Virol. 2011;2011:854540. doi: 10.1155/2011/854540. Epub 2011 Jul 27.
7
Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.用于检测人类血液样本中异嗜性鼠白血病病毒相关病毒的核酸、抗体和病毒培养方法。
Adv Virol. 2011;2011:272193. doi: 10.1155/2011/272193. Epub 2011 Nov 17.
8
Development and application of a high-throughput microneutralization assay: lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors.高通量微量中和测定法的建立与应用：献血者中未检出异嗜性鼠白血病病毒相关病毒和/或鼠白血病病毒。
Transfusion. 2012 Feb;52(2):332-42. doi: 10.1111/j.1537-2995.2011.03519.x.
9
The third described case of transfusion-transmitted Babesia duncani.第三例经输血传播的巴贝虫病。
Transfusion. 2012 Jul;52(7):1517-22. doi: 10.1111/j.1537-2995.2011.03467.x. Epub 2011 Dec 13.
10
No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome.在加拿大慢性疲劳综合征患者中未发现 XMRV 核酸、感染性病毒或抗 XMRV 抗体。
PLoS One. 2011;6(11):e27870. doi: 10.1371/journal.pone.0027870. Epub 2011 Nov 17.
Zotero 插件